Patent Law Weblog
recent posts
- Retired Judges File Amicus Brief in Support of Judge Newman
- Hikma v. Amarin at the Supreme Court: The Parties’ Opening Briefs
- Teva Pharmaceuticals International v. Eli Lilly & Co. (Fed. Cir. 2026)
- USPTO Extends Artificial Intelligence Search Automated Pilot Program (ASAP!)
- USPTO Announces That It Has Turned the Corner on Unexamined Application Backlog
about
Month: June 2017
-
By Andrew Williams — On June 27, 2017, the U.S. Food and Drug Administration issued a press release stating how it would begin implementing its plan to increase competition for prescription drugs. This comes on the heels of FDA Commissioner Scott Gottlieb's blog post last week, in which he indicated that the FDA would begin…
-
An Obviousness Rejection in Patent-Eligibility Clothing? By Michael Borella — In Mayo v. Prometheus, the Supreme Court wrote "[w]e recognize that, in evaluating the significance of additional steps, the § 101 patent-eligibility inquiry and, say, the § 102 novelty inquiry might sometimes overlap." The ongoing existence of this overlap has resulted in a catch-22 for patentees…
-
By Josh Rich — Patent applicants dissatisfied with final outcome of patent prosecution proceedings have long had two options for court review of a Patent and Trademark Appeal Board decision: an appeal to the Federal Circuit under 35 U.S.C. § 141 or a civil action in the Eastern District of Virginia under 35 U.S.C. §…
-
By Kevin E. Noonan – Most people have had the experience of becoming lost and, having arrived at their destination, realizing that it was only one false turn that caused their confusion. For those with a physics background one can recall the feature of vector calculus that a small displacement at a first position can result…
-
District Court Overrules Defendants' Objections to Magistrate's Report on Lost Profits By Donald Zuhn — Earlier this month, in GlaxoSmithKline LLC v. Glenmark Pharmaceuticals Inc., U.S. District Judge Leonard P. Stark of the U.S. District Court for the District of Delaware issued a Memorandum Order that, inter alia, overruled objections by Defendants Glenmark Pharmaceuticals Inc.,…
-
June 27, 2017 – "CRISPR Confusion: A Legal and Practical Analysis for IP Professionals" (Technology Transfer Tactics) – 1:00 to 2:00 pm (Eastern) June 27, 2017 – "Essential Developments in Patent Subject Matter Eligibility: What Lies Ahead in 2017?" (The Knowledge Group) – 12:00 to 2:00 pm (EST) June 28, 2017 – "Exhaustion Unleashed: Licensing,…
-
The Intellectual Property Owners Association (IPO) will offer a one-hour webinar entitled "Exhaustion Unleashed: Licensing, Other Business Strategy, and Litigation after Lexmark" on June 28, 2017 from 2:00 to 3:00 pm (ET). Paul Jahn of Morrison & Foerster LLP; William Krovatin of Merck & Co., Inc.; and Richard Rainey of Covington & Burling LLP will…
-
Strafford will be offering a webinar/teleconference entitled "Labeling and Induced Infringement in Pharma Patent Litigation and Protecting IP Rights" on July 13, 2017 from 1:00 to 2:30 pm (EDT). Thomas L. Irving and Barbara R. Rudolph of Finnegan Henderson Farabow Garrett & Dunner will provide guidance to patent counsel on the implications of recent cases…
-
The Intellectual Property Law Association of Chicago (IPLAC) International Patent Committee will be offering a seminar on "Important Developments in Japanese Patent Law" by Kisaragi Associates on June 30, 2017 from 5:00 to 6:00 pm (CT) in Chicago, IL. The seminar will provide important guidance on important developments in Japanese Patent Law and Administrative Practices,…
-
The Knowledge Group will offer a live webcast entitled "Essential Developments in Patent Subject Matter Eligibility: What Lies Ahead in 2017?" on June 27, 2017 from 12:00 to 2:00 pm (EST). Fang Xie of Greenberg Traurig, LLP; Robert McFarlane of Hanson Bridgett LLP; Mark Thronson of Blank Rome LLP; and Alison Maddeford of Riley Safer…
Patent Docs 